Many say yesterday's announcement was primarily in response to public pressure over new generation melanoma drugs. Pharmac yesterday announced funding for Opdivo, an advanced melanoma drug in the same class as Keytruda.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
